All the news Showing 10 of 57 articles from: Hepatocellular carcinoma (HCC)Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Liver Stiffness Before Hepatitis C Treatment Predicts Liver Cancer Risk Hep Mag / 18 January 2021 HCV-Related Liver Cancer Incidence Dropped in US Cohort Medscape / 28 September 2020 Models can help predict liver cancer in people cured of hepatitis C Liz Highleyman / 17 September 2020 Three new methods using readily available clinical parameters can help predict who will develop hepatocellular carcinoma (HCC) after achieving sustained virological response to hepatitis C treatment, according to studies presented at the recent 2020 Digital ... Immunotherapy combinations show promise for advanced liver cancer Liz Highleyman / 02 September 2020 Three checkpoint inhibitor immunotherapy regimens show promise for people with hepatocellular carcinoma (HCC), the most common type of liver cancer, according to a set of late-breaking presentations last week at the 2020 Digital ... Liver cancer risk after hepatitis C cure is lower in people with HIV Keith Alcorn / 24 August 2020 People with HIV who were cured of hepatitis C were less likely than HIV-negative people to develop hepatocellular carcinoma (HCC – liver cancer) in the three-and-a-half years after completing hepatitis C treatment, Spanish ... Racial inequalities in liver cancer deaths soared after launch of hepatitis C drugs Florida Atlantic University / 18 May 2020 A healthy lifestyle could prevent most liver cancer and liver-related deaths Liz Highleyman / 17 December 2019 A healthy lifestyle, including smoking cessation, moderate drinking, a balanced diet, exercise and weight loss could dramatically reduce the growing burden of liver cancer and deaths due to liver disease, according to a study ... Sustained response to HCV antivirals boosts liver cancer survival Liz Highleyman / 19 November 2019 People with liver cancer who achieved a sustained virological response (SVR) to direct-acting antiviral (DAA) therapy for hepatitis C saw a reduction in both liver-related and all-cause mortality over five years, according to ... When is the right time to treat hepatitis C in people with liver cancer? Keith Alcorn / 27 October 2019 Direct-acting antiviral treatment for hepatitis C need not be delayed until the completion of treatment for hepatocellular carcinoma (HCC; liver cancer), but people with hepatitis C need to be warned of a ... Fatty livers halt tumor-suppressing protein, increasing cancer risk Fierce Biotech / 21 October 2019 ← First12345...6Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds